Parallel investigations should focus on evaluating OC’s impact on PAR-2-driven secretion of chemokines such as CCL2/MCP-1, which contribute to tumor-associated macrophage (TAM) recruitment and immune evasion. The gene discussed is CCL2; the disease is neoplasm.